JPRN-jRCT1080223694已完成未知
A prospective, open label, controlled, randomized, multicenter study to assess the efficacy and safety of CLBS12 in patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) with a single-arm substudy to assess the safety and potential efficacy of CLBS12 in patients with CLI due to Buerger's Disease (BD)
EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)0 个研究点目标入组 35 人开始时间: 2017年10月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •Subject has CLI caused by ASO or BD
排除标准
- •< 20 years old
研究者
相似试验
招募中
1 期
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptomsPsoriatic arthritisMedDRA version: 21.1Level: PTClassification code: 10037162Term: Psoriatic arthropathy Class: 100000004859CTIS2023-508251-39-00niversitaetsklinikum Erlangen AöR370
进行中（未招募）
1 期
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptomsPsoriatic arthritisEUCTR2020-001899-14-DEniversitätsklinikum Erlangen270
已完成
不适用
A randomised comparison of two different methods of intrabronchial lignocaine delivery during flexible bronchoscopySurgeryAnaesthesiaocal anaesthetic delivery in bronchoscopyISRCTN77331907ancashire Teaching Hospitals NHS Trust (UK)100
已完成
不适用
A prospective, open label, randomized, controlled trial of tocilizumab versus cyclophosphamide in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011244Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology40
招募中
4 期
Effect of high protein supplement on muscle strength, muscle mass andphysical function in elderly population.CTRI/2024/03/064441Hindustan Unilever Limited